Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1846, Issue 1, Pages 201-215Publisher
ELSEVIER
DOI: 10.1016/j.bbcan.2014.07.004
Keywords
Poly(ADP-ribose) polymerase; BRCAness; Tankyrase; DNA repair; Synthetic lethality; Targeted cancer therapies
Categories
Funding
- AIRC, Associazione Italiana per la Ricerca sul Cancro - Special Program Molecular Clinical Oncology 5parts per thousand [9970]
- AIRC Investigator Grants [10116, 14205]
- Fondazione Piemontese per la Ricerca sul Cancro-ONLUS, 5x1000 Ministero della Salute
Ask authors/readers for more resources
Inhibitors of poly(ADP-ribose) polymerases actualized the biological concept of synthetic lethality in the clinical practice, yielding a paradigmatic example of translational medicine. The profound sensitivity of tumors with germline BRCA mutations to PARP1/2 blockade owes to inherent defects of the BRCA-dependent homologous recombination machinery, which are unleashed by interruption of PARP DNA repair activity and lead to DNA damage overload and cell death. Conversely, aspirant BRCA-like tumors harboring somatic DNA repair dysfunctions (a vast entity of genetic and epigenetic defects known as BRCAness) not always align with the familial counterpart and appear not to be equally sensitive to PARP inhibition. The acquisition of secondary resistance in initially responsive patients and the lack of standardized biomarkers to identify BRCAness pose serious threats to the clinical advance of PARP inhibitors; a feeling is also emerging that a BRCA-centered perspective might have missed the influence of additional, not negligible and DNA repair-independent PARP contributions onto therapy outcome. While regulatory approval for PARP1/2 inhibitors is still pending, novel therapeutic opportunities are sprouting from different branches of the PARP family, although they remain immature for clinical extrapolation. This review is an endeavor to provide a comprehensive appraisal of the multifaceted biology of PARPs and their evolving impact on cancer therapeutics. (C) 2014 The Authors. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available